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Background. Quantitative estimates of the global burden of the 1957 influenza pandemic are lacking. Here we fill this gap by
modeling historical mortality statistics.
Methods. We used annual rates of age- and cause-specific deaths to estimate pandemic-related mortality in excess of background
levels in 39 countries in Europe, the Asia-Pacific region, and the Americas. We modeled the relationship between excess mortality
and development indicators to extrapolate the global burden of the pandemic.
Results. The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95% confidence interval [CI],
1.2–2.6 cases/10 000 population) on average during 1957–1959. Excess mortality rates varied 70-fold across countries; Europe
and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1–2 years in 18 countries
(46%). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence
that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, ex-
plaining 35%–77% of the variance. Overall, we attribute 1.1 million excess deaths (95% CI, .7 million–1.5 million excess deaths)
globally to the 1957–1959 pandemic.
Conclusions. The global mortality rate of the 1957–1959 influenza pandemic was moderate relative to that of the 1918 pandemic
but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in
several countries, pointing to a window of opportunity for vaccination in a future pandemic.
Keywords. mortality rates; pandemic influenza; historical studies; vital statistics; severity; models; global disease burden;
development indicators; health indicators; pandemic planning.
Quantitative studies of the mortality impact of past influenza
pandemics are important to inform pandemic preparedness ef-
forts but are hampered by a paucity of historical data sets and
substantial heterogeneity in the experience of individual coun-
tries [1]. Much has been written about the devastating 1918
pandemic, as well as the recent 2009 pandemic. However, the
1957 and 1968 pandemics have received considerably less atten-
tion [2–4]. In particular, no quantitative global mortality esti-
mates are available for the 1957 and 1968 pandemics, even
though both pandemics inform preparedness efforts for moder-
ate severity pandemics [5]. The relationship between economic
development and pandemic-related mortality rates appears
moderate for the 1918 pandemic [2] and weaker for the 2009
pandemic [3], but the strength of the relationship remains un-
certain for other pandemics.
Here we focus on the 1957 pandemic, for which multicountry
comparative epidemiological studies are lacking. Much of the
world experienced sustained pandemic influenza A(H2N2) virus
transmission by December 1957, with recurrent waves of pan-
demic activity occurring over several years [6, 7]. Quantitative
studies of excess mortality associated with the 1957 influenza pan-
demic have been limited to a few economically developed coun-
tries, including the United States, Canada, England and Wales,
Germany, and Singapore [7–9], with age-specific estimates avail-
able for the United States and Canada only [6, 7, 10]. No informa-
tion is available from Latin America, Africa, the Middle East, or
Eastern Europe. Here we used a detailed World health Organiza-
tion (WHO) mortality database to infer the mortality burden of
the 1957 influenza pandemic in 39 countries with adequate data.
We modeled the relationship between country-specific develop-
ment indicators and pandemic mortality and extrapolated this re-




We compiled annual age- and cause-specific mortality statistics
from the WHO Cause of Death Query Online database [11],
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selecting all countries that had data for 1955–1965 or longer.
Choice of this minimum study period allowed for fitting nonpan-
demic mortality baseline values and capturing potential recrudes-
cent pandemic waves throughout 1957–1959, while remaining
inclusive.We used the International Classification of Diseases, Sev-
enth Revision, to tabulate deaths with underlying causes coded as
pneumonia and influenza, respiratory diseases, and respiratory
and cardiac diseases (disease codes are available in Supplementary
Table 1). Our main analysis was based on respiratory deaths,
available for 39 countries, while sensitivity analyses were based
on deaths from respiratory and cardiac causes (a more sensitive
outcome available for 39 countries) and pneumonia and influenza
(a more specific outcome available for 46 countries).
Deaths counts were tabulated for 7 age groups (0–4, 5–14,
15–24, 25–49, 50–64, ≥65 years, and all ages). Annual age-
specific population data were obtained from the same WHO
database [11]; population estimates for missing years were in-
terpolated by thin-plate smoothing splines.
Indicators of Development
We queried Gapminder [12] to compile country-specific gross
domestic product (GDP) and gross national income estimates
for 1960–1975 and infant mortality rates for 1950–1970. Data
were available for 122 countries, including the 46 countries in
our mortality data set, representing 82% of the world popula-
tion. Development indicators were interpolated by spline for
unavailable years; we used estimates for 1957 for comparison
with influenza mortality estimates. Baseline cause-specific mor-
tality rates (available for countries providing data to the WHO
database [11]) were also considered as indicators of development.
Statistical Analysis
We adapted a so-called excess-mortality approach previously de-
veloped to estimate the global burden of the 1918 pandemic on
the basis of annual mortality data [2]. Because mortality rates
showed marked time trends during the 1950s in most countries,
we fit spline functions to annual mortality time series to infer base-
line mortality. Separate models were fitted to each country, cause of
death (all-cause death, death due to respiratory diseases, and death
due to pneumonia and influenza), and age group (Supplementary
Figures 1 and 2). Pandemic years 1957–1959 were excluded from
baseline calculations; we also excluded 1951 for the United King-
dom, Ireland, and Canada, which coincided with the occurrence of
an unusually severe influenza season that resulted in substantial in-
crease in mortality due to respiratory causes [8]. Pandemic-related
excess mortality was estimated as the observed mortality in 1957
minus the modeled baseline mortality. We also assessed the occur-
rence of second and third pandemic-associated waves of excess
mortality in 1958 and 1959. We also tabulated the proportion of
excess deaths occurring in each age group and the elevation
above the baseline level during the 3-year pandemic period.
To explore the association between pandemic excess mortal-
ity rates and indicators of development, we fit univariate and
multivariate linear regression models with excess mortality
rates as the outcome and development indicators as covariates,
separately by age group and death outcome.
To extrapolate the global burden of the pandemic, we applied
the regression model developed for countries with available vital
statistics data (39 countries for respiratory and cardiorespiratory
disease outcomes and 46 countries for pneumonia and influen-
za outcomes) to the larger sample of 122 countries in our data
set, using socioeconomic and health indicators as predictors.
We generated 95% confidence intervals (CIs) by bootstrap.
RESULTS
Pandemic-Associated Rates of Excess Mortality Due to Respiratory
Diseases
Our main analysis focused on estimates of pandemic-related
excess mortality in 1957 and during 1957–1959 for 39 countries
reporting deaths due to respiratory diseases. There was a >70-
fold difference in pandemic-associated excess respiratory mor-
tality rates in 1957 between countries, ranging from no measur-
able impact in Egypt to 5.5 deaths/10 000 population in Chile
(Figure 1, Table 1, and Supplementary Table 2). The 10 coun-
tries with lowest excess mortality included European countries
and Egypt, whereas the 5 countries with highest excess mortality
included Latin American countries and Finland. Cumulative ex-
cess pandemic mortality rates for the 1957–1959 period ranged
from 0.3 deaths/10 000 population (Egypt) to 9.8 deaths/10 000
population (Chile), a 30-fold difference. Of the 39 countries,
the impact on excess mortality in 18 (44%) was delayed to the
second or third year of pandemic virus circulation. In Europe
and Australia in particular, the majority of influenza-related
deaths occurred in the third year of pandemic influenza A
(H2N2) virus activity (Supplementary Table 2).
Age-specific excess mortality rates were highest at both ex-
tremes of the age spectrum (Table 2). However, when excess
mortality was compared to baseline mortality rates, the age
groups with highest relative burden were 15–24 years (34% el-
evation over baseline mortality levels for the 3-year period of
1957–1959), followed by 5–14 years (27% increase over baseline;
Figure 1 and Table 2). In contrast, children aged <5 years and se-
niors aged ≥65 years only experienced a minor elevation over
baseline (8%; Table 2). The sharp mortality elevation in school-
aged children and young adults was consistent throughout Europe
(Figure 1), even though the all-age impact of the pandemic on
mortality was generally low in this region.
Relationship With Development Indicators
Development indicators such as GDP, infant mortality rates, base-
line respiratory death rates, and latitude were weakly associated
with pandemic-related excess mortality rates due to respiratory
diseases in univariate analyses, explaining 6%–35% of differences
between countries (P < .006; Table 3). Stepwise multivariate re-
gression indicated that GDP was the sole predictor of cumulative
excess mortality due to respiratory diseases during 1957–1959,










Figure 1. Country-specific influenza-related excess mortality rates from respiratory causes, 1950–1970. Excess mortality rate is calculated as the observed annual mortality
rate minus a model-predicted spline baseline fitted to the mortality rate outside the 1957–1959 pandemic period. The 2 black vertical lines highlight mortality attributable to the
pandemic period. A, All-age mortality. B, Mortality among individuals aged 15–24 years, the age group with the highest increase in mortality, relative to baseline, during the
pandemic period. Mortality rates range from low (yellow) to high (red). Abbreviation: SAR, Special Administrative Region.










explaining 28% of the variance, while GDP and latitude explained
43% of the variance in excess mortality during 1957. Standardiz-
ing burden estimates by baseline respiratory death rates reduced
but did not eliminate differences between countries.
On the basis of the modeled relationship between excess
mortality rates due to respiratory diseases, GDP, and latitude,
we extrapolated the pandemic burden to 122 countries with
available information on development indicators (Table 1 and
Figure 2). We estimate a global excess mortality rate of 4.0
deaths/10 000 population (95% CI, 2.6–5.3 deaths/10 000 pop-
ulation) during 1957–1959, corresponding to 1.1 million excess
deaths (95% CI, .7 million–1.5 million excess deaths) due to re-
spiratory diseases in the 1957 world population.
Predictors of pandemic-related mortality varied with age.
Predictors included infant mortality for children aged <5
years, GDP for seniors, and baseline respiratory mortality for
intermediate age groups (this factor alone explained 87%–99%
of the variance). The global excess respiratory mortality rate
extrapolated from age-specific data was 5.2 deaths/10 000 pop-
ulation (95% CI, 3.3–7.4 deaths/10 000 population) for the
1957–1959 pandemic period (Table 2). Two-thirds of pandemic-
related deaths were among individuals <65 years of age.
Sensitivity Analysis Using Different Disease Outcomes
Similar geographic differences and pandemic predictors were
obtained in analyses of mortality due to pneumonia and influ-
enza, a more specific outcome that was available for a larger
Table 1. Global Pandemic Influenza Mortality Burden Estimates for 1957
and for the 3-Year Period 1957–1959





Population-weighted mean for select countriesa
Deaths due to pneumonia and influenzab 1.2 (.8–1.6) 1.8 (1.3–2.6)
Deaths due respiratory diseasesc 1.3 (.8–1.9) 1.9 (1.3–2.9)
Deaths due cardiorespiratory diseasesc 1.5 (.9–2.1) 2.4 (1.8–3.0)
Global extrapolationd
Deaths due to pneumonia and influenza 1.7 (1.3–2.2) 2.9 (2.1–3.8)
Deaths due respiratory diseases 2.3 (1.6–2.9) 4.0 (2.6–5.3)
Deaths due cardiorespiratory diseases 2.4 (1.6–3.1) 4.0 (2.8–5.1)
Abbreviations: CI, confidence interval; ICD-7, International Classification of Diseases,
Seventh Revision.
a Estimates are for countries with adequately detailed vital statistics data in the World Health
Organization mortality database. Estimates of pandemic-related excess mortality rates are
based on the difference between the observed mortality rate during pandemic years and
a model-predicted spline baseline rate fitted to the mortality rate in the surrounding years.
b Data are for 46 countries, using ICD-7A or ICD-7B codes.
c Data are for 39 countries, using ICD-7A codes.
d Pandemic mortality rates were extrapolated to 122 countries, using the observed
relationship between country-specific mortality estimates and development indicators.
Data are based on a multivariate model including gross domestic product and latitude as
predictors; 95% CIs rely on bootstrapping. See Supplementary Table 2 for country-specific
mortality estimates.
Table 2. Age-Specific Estimates of the Global Pandemic-Related Mortality Burden
Age Group, y
Excess Respiratory Deaths/10 000
Population, Mean of













0–4 10.44 (5.16–16.48) 0.08 (.06–.11) 15.99 (10.19–21.82) 659 700 ± 119 900 44.1
5–14 0.63 (.48–.81) 0.27 (.21–.35) 0.93 (.71–1.15) 61 900 ± 7400 4.1
15–24 0.55 (.42–.73) 0.34 (.26–.42) 0.89 (.46–1.47) 40 100 ± 11 300 2.7
25–49 0.67 (.48–.97) 0.16 (.13–.19) 1.12 (.64–1.67) 94 500 ± 21 700 6.3
50–64 3.17 (2.39–4.32) 0.13 (.11–.17) 5.46 (3.68–7.48) 155 000 ± 26 900 10.3
≥65 12.93 (8.5–19.6) 0.08 (.05–.13) 23.3 (14.43–34.66) 486 300 ± 105 500 32.5
Overall 3.43 (2.1–5.06) 0.14 (.06–.32) 5.23 (3.31–7.4) 1 488 500 ± 272 000 100.0
All estimates represent cumulative excess deaths due to respiratory diseases during the 1957–1959 pandemic period.
Abbreviation: CI, confidence interval.
a Estimates are for 39 countries with adequately detailed vital statistics data.
b Relative risk (RR) is calculated as the excess respiratory disease–associatedmortality rate in 1957–1959 divided by the baseline mortality rate during 1957–1959. This ratio considers severity in
an age group or a country as a relative measure and adjusts for different levels of background mortality.
c Data are estimates extrapolated to 122 countries, using separate models based on development indicators fitted to each age group.
Table 3. Identified Predictors of Pandemic-Related Excess Mortality



















GDP −0.00315 ± 0.001 .0037





GDP −0.00257 ± 0.001 .016
Latitude −0.255 ± 0.127 .053
Regression model outcomes are deaths/10 000 population for all ages combined. Predictors
are selected by stepwise regression and based on countries with adequately detailed
mortality data.
Abbreviations: GDP, gross domestic product; SE, standard error.










sample of 46 countries (Table 1). There was a >25-fold difference
in pandemic-related excess mortality rates due to pneumonia
and influenza during 1957–1959 between countries, and base-
line mortality was the only consistent predictor in multivariate
analyses of all age and age-specific data (P < .02). The bottom
10 countries for excess mortality included Europe, the United
States, Israel, and Egypt, while the top excess mortality rates
were found in Latin American countries, with Chile faring
the worst, in line with our main analysis. Extrapolation indi-
cated a global excess mortality rate due to pneumonia and in-
fluenza of 2.9 deaths/10 000 population (95% CI, 2.1–3.8
deaths/10 000 population) during 1957–1959, thus capturing
73% of our global estimate based on the broader respiratory
death outcome (Table 1).
Analysis of cardiorespiratory deaths, a more sensitive mortal-
ity outcome available in 39 countries, provided results nearly
identical to those of deaths due to respiratory diseases in
terms of excess mortality predictors and global extrapolations
(Tables 1 and 3). Across all analyses, the average pandemic-
related excess mortality rates in the countries with available
vital statistics data were 30%–50% lower than our global extrap-
olations based on regression models applied to 122 world coun-
tries (Table 1).
DISCUSSION
To our knowledge, this is the first study to generate global mor-
tality estimates for the 1957 pandemic that are grounded in
analysis of mortality data from multiple countries. We used
WHOmortality databases to generate estimates and explore be-
tween-country variation in pandemic burden in a diverse set of
regions. Infection with pandemic influenza A(H2N2) virus was
associated with 4.0 excess deaths due to respiratory diseases per
10 000 population (95% CI, 2.6–5.3 deaths/10 000 popula-
tion) over the first 3 years of circulation, during 1957–1959,
Figure 2. Global maps of pandemic influenza–related mortality rates during the 1957–1959 pandemic period. Estimates are based on 39 countries with available respiratory
disease–related mortality data (top panel) and model extrapolation to 122 world countries based on development and geographic indicators (bottom panel).










corresponding to 1.1 million deaths globally (95% CI, .7 million–
1.5 million deaths). Of the countries with available vital statis-
tics data, we found a 25–70-fold variation in excess mortality
rate estimates for the pandemic period of 1957–1959, depend-
ing on the cause of death considered, with even more-
pronounced variation in the first year of pandemic virus
circulation. Development indicators such as GDP, infant
mortality, and baseline respiratory mortality rates, as well as
latitude, were moderate predictors of excess mortality rates.
Interestingly, the brunt of pandemic’s impact was delayed to
the second and third year of pandemic virus circulation in
44% of countries with WHO data.
Traditional influenza-associated excess mortality studies have
relied on seasonal regression of weekly or monthly mortality sta-
tistics, but such data are lacking for the period relevant to the
1957–1959 pandemic for most countries. Instead, we used an an-
nualized approach adapted from a study of the 1918 pandemic
[2], in which we estimated annual mortality occurring in excess
of a flexible model baseline value fitted to surrounding years. Un-
like the previous study [2], however, we considered cause-specific
deaths, including those due to pneumonia and influenza, respira-
tory diseases, and cardiorespiratory diseases, rather than all-cause
mortality, which increases the specificity of our estimates.
We checked the validity of our approach for Chile, the United
States, and Canada, where both annual and monthly vital statis-
tics were available [6, 7, 10, 13]. Reassuringly, estimates for Chile
were highly consistent between the annualized approach and
traditional seasonal regression methods relying on temporally
disaggregated data [13]. For Canada and the United States,
our estimates for the first wave of the 1957 pandemic, based
on annual all-age data, were substantially lower than those re-
ported earlier, although age-specific estimates were more con-
sistent, especially for individuals aged <65 years [6, 7, 10].
This is due in part to the relatively mild nature of this pandemic
in the United States and Canada and to the preponderance of
age groups with high baseline mortality levels in aggregated
all-age data, particularly those involving infants and elderly in-
dividuals [6–8, 14]. This so-called drowning effect may explain
why global extrapolations based on age-specific data were con-
sistently higher than those based on all-age data, suggesting that
age-specific extrapolations may be more valid.
Another limitation of our annual approach is that we cannot
remove the effect of seasonal influenza epidemics from the
baseline, except for the unusual occurrence of well-character-
ized severe influenza seasons, such as the 1951 epidemic in
the United Kingdom, Ireland, and Canada [8]. Similarly, we
cannot remove the effect of unusual outbreaks of other respira-
tory pathogens in baseline calculations. Overall, our pandemic
estimates measure the amount of excess mortality occurring
above and beyond that of typical seasons, which include the
combined effect of many pathogens, and hence these estimates
should be regarded as conservative.
We also considered other potential sources of increased mor-
tality related to natural disasters and military unrest as a poten-
tial source of mismeasurement. We identified 6 events relevant
to our study period, including 4 military coups (in Colombia,
Venezuela, El Salvador, and Panama), a war (in Egypt), and
an earthquake (in Chile). Five of these events did not result in
elevated cause-specific mortality (mortality due to cardiorespi-
ratory and respiratory diseases in years coinciding with these
events were either below or within 5% of baseline). The 6th
notable event relates to a military coup in Venezuela in 1958,
coinciding with a 19% mortality elevation over baseline. How-
ever, mortality rates were even higher in 1957, the first year of
the pandemic, and remained elevated in 1959, the third year of
pandemic virus circulation, suggesting that the observed mor-
tality elevation is part of a long-lasting pandemic effect rather
than due to civil unrest. Further substantiation of this argument
is provided by the age patterns of deaths in Venezuela, as the
increase in mortality during 1958 was most pronounced in
the 5–24-year age group and most attenuated in other age
groups, as would be expected if such elevation were caused by
the pandemic.
Overall, despite uncertainty in some of our lower end esti-
mates, our large multinational sample convincingly indicates
that Latin America—and particularly Chile—fared substantially
worse than other regions. Further, the full range of global extrap-
olations provided in this study by use of different approaches
should be considered as plausible estimates of the 1957–1959
pandemic burden (0.7 million–2.1 million excess deaths, corre-
sponding to mortality rates of 2.6–7.4 deaths/10 000 population).
Our country-level analysis revealed great (25–70-fold) geo-
graphic variation in the pandemic-related mortality burden, ex-
plained in part by health and economic disparities (with the
latter explaining 37%–99% of variance for various mortality
outcomes). A multinational study of the 1918 pandemic report-
ed 30-fold variation in excess mortality rates across 27 coun-
tries; approximately 50% of the variance could be attributed
to differences in income, but health indicators such as infant
mortality or respiratory death rates were not studied [2].
Substantial residual variation in mortality remained in our
study after adjustment for development indicators, including
among neighboring countries. For example, Finland experi-
enced substantially higher mortality than Denmark, the Neth-
erlands, or Sweden. In addition, the extremely low impact of
pandemic-related mortality in Egypt is notable; however, the
lack of additional mortality data from the region precludes fur-
ther comparison. Owing to the lack of relevant vital statistics
data, our global model extrapolated to 122 countries did not in-
clude potentially important health covariates, such as back-
ground respiratory mortality rates. In this study, we have
shown that background cause-specific mortality can be an im-
portant predictor of the pandemic-related mortality burden, es-
pecially for highly specific outcomes, such as pneumonia and










influenza. Moving forward, accurate projection of the disease
burden of future pandemic events would require availability
of these covariates for a large sample of countries.
Between-country variation could be attributed in part to dif-
ferences in prior immunity, as prior experience with influenza
A(H1N1) virus may have reduced the severity of influenza
A(H2N2) virus infection, although the mechanisms of cross-
subtypic immunity remain debated [15]. It is worth noting that
a severe epidemic of influenza A(H1N1) infection swept through
the United Kingdom, the northeastern United States, and Can-
ada in 1951 [8] and featured as a season with a high mortality
rate in some of the studied countries. Although information on
global influenza virus strain circulation is scarce prior to 1957,
heterogeneity in exposure to influenza A(H1N1) virus could
have affected baseline immunity to the 1957 pandemic virus.
Alternatively, seasons of severe influenza A(H1N1) virus infec-
tion could have resulted in the death of frail individuals prior to
the emergence of the pandemic influenza A(H2N2) virus in
some regions.
Our regression models indicate that mortality predictors var-
ied by age and mortality outcome. In particular, baseline mortal-
ity rates were strong predictors of pandemic-related excess
mortality due to pneumonia and influenza, while GDP was a bet-
ter predictor of broader disease outcomes. The infant mortality
rate was a strong predictor of pandemic-related excess mortality
in children <5 years of age, perhaps because infant mortality is a
fair indicator of infectious diseases–related health issues in youn-
ger age groups. Interestingly, high GDP was predictive of high ex-
cess mortality among seniors, perhaps because a higher GDP
correlates with a greater share of older age groups demographi-
cally and greater prevalence of comorbid conditions. Overall, es-
timates for the youngest and oldest segments of the population
have to be taken with caution because of the use of an annual ap-
proach and the high background death rate of these age groups
[14]. In contrast, mortality estimates for intermediate age groups
are more specific and robust, especially for teenagers and young
adults, who were particularly affected by this pandemic.
Geographic variation in excess mortality rates was reduced by
standardizing burden estimates by baseline rates of death, sug-
gesting that underlying coding practices may affect disease esti-
mates. In particular, Chile was a clear outlier in the magnitude
of mortality due to pneumonia and influenza and to respiratory
diseases, even in prepandemic seasons, with 2–3-fold higher
baseline rates than Colombia. Such a large difference could in
principle reflect a higher propensity of doctors to assign deaths
to respiratory illnesses in Chile; however, the magnitude of
pandemic-related estimates of mortality due to cardiorespira-
tory diseases in this country indicates this is not simply a coding
artifact.
The sample of countries contributing historical vital statistics
data to the WHO was biased toward highly developed regions,
although we did have fair representation of low-income
countries, including several countries (such as Chile) with a
GDP of less than $2000/year. Our global extrapolation model
infers high pandemic-related excess mortality rates in low-
income countries underrepresented in our sample, which drives
global estimates upward. This explains why our globally extrap-
olated pandemic rates are 33%–50% higher than the average ex-
cess mortality rate estimated for countries with historical data.
Our study covered a broad geographic scope, including the
Americas, Europe, and the Asia-Pacific region; however, we
did not have any data from Africa. As in other international in-
fluenza studies [2, 3], the paucity of available data from Africa
indicates that global estimates may not be fully representative of
the global pandemic experience.
The age patterns of the 1957 pandemic have been well de-
scribed in the United States and Canada [7, 16] and align well
with our findings in a larger set of countries. We found a sharp
elevation of excess mortality rates among school-aged groups at
the time of the pandemic, with a consistent signature even in
countries mildly affected by the pandemic overall. The impact
on school-aged children was particularly pronounced in the
first year of influenza A(H2N2) virus circulation, while the im-
pact on older adults was stronger in subsequent years—a pat-
tern reminiscent of the 1918 and 2009 pandemic [17–19].
Excess mortality rates were lowest in school-aged children
and increased monotonously at older ages, in line with age-
specific excess mortality rates reported in the United States [7, 16]
and consistent with a lack of protection of the elderly popula-
tion from excess mortality (termed “senior sparing”). A seroe-
pidemiology study has reported prepandemic protective
antibodies to A/H2 in Dutch persons older than approximately
70 years [20] and is not necessarily contradictory to our data, as
it would have been nearly impossible to detect a sparing effect,
given the small population size of these age groups and the res-
olution of our data set. It is generally accepted that senior spar-
ing did not play a major role in the 1957 pandemic, in contrast
to the 1918, 1968, and 2009 pandemics, when seniors were par-
tially protected due to prior childhood exposure to antigenically
related viruses [3, 17, 21–24].
In conclusion, our study fills a gap in the availability of global
mortality estimates for historical influenza pandemics, which
can help guide pandemic planning. Our model extrapolates
2.7 million influenza-related deaths (95% CI, 1.6 million–3.4
million deaths) should a virus of similar severity to the 1957
pandemic influenza A(H2N2) virus return in the 2005 popula-
tion, which is intermediate between global estimates for the
2009 pandemic (0.3 million–0.4 million deaths [3]) and a dev-
astating 1918-like pandemic (62 million deaths; range, 51 mil-
lion–81 million deaths [2]). Overall, our study reinforces
substantial geographic variation in the pandemic-related mor-
tality burden between countries, much of which remains unex-
plained, thus echoing recent work on the 1918 and 2009
pandemic [2, 3]. Such variations indicate that the proposed










use of a pandemic severity index may be problematic unless it is
based on multiple countries representative of a spectrum of
health and economic development in several world regions.
Further, our study suggests that it is critical to both consider
the absolute and relative impact of a pandemic—by country
and age groups—to fully understand severity patterns in various
populations. In future pandemics, it will be critical to analyze
severity statistics from a number of indicator countries, to gen-
erate more-accurate estimates of the global disease burden in
near real time.
Supplementary Data
Supplementary materials are available at http://jid.oxfordjournals.org.
Consisting of data provided by the author to benefit the reader, the posted
materials are not copyedited and are the sole responsibility of the author,
so questions or comments should be addressed to the author.
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